abstract |
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and the use of said compounds, salts and combinations in the treatment of various disorders associated with CRM1 activity method of things. |